Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.5 (EPT/RI)-Spire Healthcare Group plc

22nd Sep 2025 11:28

RNS Number : 2649A
JPMorgan Securities Plc
22 September 2025
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

J.P. Morgan Securities Plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Spire Healthcare Group plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Corporate Broker to Spire Healthcare Group PLC

(d) Date dealing undertaken:

19 September 2025

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

1p ordinary

Purchase

1,151,723

2.5425 GBP

2.2650 GBP

Sale

981,189

2.5375 GBP

2.2600 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

1p ordinary

Equity Swap

Decrease Long

4,256

2.2949 GBP

1,494

2.4702 GBP

33,273

2.4726 GBP

108,219

2.4832 GBP

3

2.4900 GBP

14,880

2.5023 GBP

Decrease Short

6,312

2.3750 GBP

5,392

2.4458 GBP

1,994

2.4545 GBP

4,080

2.4613 GBP

4,615

2.4622 GBP

1,904

2.4638 GBP

6,528

2.4685 GBP

1,015

2.4718 GBP

3,065

2.4735 GBP

3,072

2.4804 GBP

10,348

2.4889 GBP

4,080

2.4998 GBP

8,160

2.5172 GBP

Increase Long

39,800

2.4651 GBP

11,528

2.4698 GBP

68

2.4700 GBP

4,693

2.4781 GBP

3,436

2.5287 GBP

Increase Short

72

2.3850 GBP

832

2.4402 GBP

573

2.4802 GBP

5,258

2.4998 GBP

5,207

2.5104 GBP

Opening a long position

25

2.4000 GBP

5,228

2.4812 GBP

1,162

2.4969 GBP

3,158

2.5198 GBP

Opening a short position

363

2.2951 GBP

1,061

2.4459 GBP

1,845

2.4540 GBP

62

2.4700 GBP

1,014

2.4701 GBP

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

Date of disclosure:

22 September 2025

Contact name:

Hetvi Shah

Telephone number:

44 2034 936359

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERLTMMTMTTTBRA

Related Shares:

Spire Healthcare
FTSE 100 Latest
Value9,657.54
Change11.92